Cardiovascular Syst (CSII)
20.00 +0.03 (+0.15%) 04/28/23 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2022 | 06-2021 | 06-2020 | 06-2019 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,933 | -13,421 | -27,236 | -255 | 1,712 |
| Depreciation Amortization | 6,269 | 5,744 | 4,070 | 3,391 | 3,934 |
| Accounts receivable | 205 | -14,821 | 9,503 | -4,915 | -2,878 |
| Other Working Capital | -11,208 | -13,058 | -8,887 | -5,161 | -6,562 |
| Other Operating Activity | 17,395 | 34,672 | 9,785 | 17,148 | 13,468 |
| Operating Cash Flow | $-24,272 | $-884 | $-12,765 | $10,208 | $9,674 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,421 | -90,998 | 1,908 | -47,742 | 194 |
| PPE Investments | -4,220 | -3,954 | -3,369 | -2,665 | -1,956 |
| Net Acquisitions | -1,700 | -3,353 | -5,741 | N/A | N/A |
| Purchase Of Investment | -12,340 | -14,404 | -750 | -3,055 | -2,538 |
| Purchase Sale Intangibles | 0 | 0 | -717 | -890 | -1,113 |
| Other Investing Activity | 0 | 0 | -717 | -890 | -795 |
| Investing Cash Flow | $22,161 | $-112,709 | $-8,669 | $-54,352 | $-5,095 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,054 | 4,238 | 139,055 | 3,948 | 3,755 |
| Common Stock Repurchased | -5,367 | -4,884 | -6,303 | -1,791 | 0 |
| Other Financing Activity | -222 | -154 | -92 | -36 | 14 |
| Financing Cash Flow | $-2,535 | $-800 | $132,660 | $2,121 | $3,769 |
| Beginning Cash Position | 71,070 | 185,463 | 74,237 | 116,260 | 107,912 |
| End Cash Position | 66,424 | 71,070 | 185,463 | 74,237 | 116,260 |
| Net Cash Flow | $-4,646 | $-114,393 | $111,226 | $-42,023 | $8,348 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,272 | -884 | -12,765 | 10,208 | 9,674 |
| Capital Expenditure | -4,220 | -3,954 | -3,369 | -2,665 | -1,956 |
| Free Cash Flow | -28,492 | -4,838 | -16,134 | 7,543 | 7,718 |